CHLORPROMAZINE IN THE TREATMENT OF MENTAL ILLNESS. IV: FINAL RESULTS WITH ANALYSIS OF DATA ON 1,523 PATIENTS
Abstract
1. Of 1, 523 patients treated with chlorpromazine from 1-15 months, 81.8% showed improvement.
2. Problems concerning dose, side-effects, and clinical results have been considered.
3. Female patients used higher doses, had a proportionately larger number of sideeffects, and showed a better discharge rate than males.
4. Some theoretical considerations of these findings have been reviewed.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
